{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:04:27Z","timestamp":1779278667417,"version":"3.51.4"},"reference-count":31,"publisher":"The Company of Biologists","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,1,15]]},"abstract":"<jats:p>Angiogenic regulators modulate endothelial cell functions, including proliferation, migration, secretion, and adhesion, through their action on endothelial cells or other cell types. TWEAK, a novel member of the tumor necrosis factor family, appears to be a pro-angiogenic agent on the basis of previous studies demonstrating its ability to induce interleukin-8 production by epithelial tumor lines, stimulate proliferation of human vascular cell types and neovascularization in rat corneas. Here, we further characterized the angiogenic potential of TWEAK, revealing a dual role for TWEAK as an angiogenic regulator. We demonstrate that TWEAK is a potent inducer of endothelial cell survival and cooperates with basic fibroblast growth factor to induce the proliferation and migration of human endothelial cells and morphogenesis of capillary lumens. In contrast, TWEAK antagonizes the morphogenic response of endothelial cells to vascular endothelial growth factor (VEGF) without inhibiting VEGF-induced survival or proliferation. Thus, our observations suggest that TWEAK may differentially regulate microvascular growth, remodeling and\/or maintenance in vivo, depending upon the angiogenic context.<\/jats:p>","DOI":"10.1242\/jcs.115.2.267","type":"journal-article","created":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T23:31:25Z","timestamp":1619393485000},"page":"267-274","source":"Crossref","is-referenced-by-count":93,"title":["Dual role for TWEAK in angiogenic regulation"],"prefix":"10.1242","volume":"115","author":[{"given":"Aniela","family":"Jakubowski","sequence":"first","affiliation":[{"name":"Departments of Exploratory Science, Molecular Genetics and Protein Engineering, Biogen Inc., 12 Cambridge Center, Cambridge, Massachusetts 02142, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Browning","sequence":"additional","affiliation":[{"name":"Departments of Exploratory Science, Molecular Genetics and Protein Engineering, Biogen Inc., 12 Cambridge Center, Cambridge, Massachusetts 02142, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matvey","family":"Lukashev","sequence":"additional","affiliation":[{"name":"Departments of Exploratory Science, Molecular Genetics and Protein Engineering, Biogen Inc., 12 Cambridge Center, Cambridge, Massachusetts 02142, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Sizing","sequence":"additional","affiliation":[{"name":"Departments of Exploratory Science, Molecular Genetics and Protein Engineering, Biogen Inc., 12 Cambridge Center, Cambridge, Massachusetts 02142, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey S.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Departments of Exploratory Science, Molecular Genetics and Protein Engineering, Biogen Inc., 12 Cambridge Center, Cambridge, Massachusetts 02142, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher D.","family":"Benjamin","sequence":"additional","affiliation":[{"name":"Departments of Exploratory Science, Molecular Genetics and Protein Engineering, Biogen Inc., 12 Cambridge Center, Cambridge, Massachusetts 02142, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Ming","family":"Hsu","sequence":"additional","affiliation":[{"name":"Departments of Exploratory Science, Molecular Genetics and Protein Engineering, Biogen Inc., 12 Cambridge Center, Cambridge, Massachusetts 02142, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Ambrose","sequence":"additional","affiliation":[{"name":"Departments of Exploratory Science, Molecular Genetics and Protein Engineering, Biogen Inc., 12 Cambridge Center, Cambridge, Massachusetts 02142, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy S.","family":"Zheng","sequence":"additional","affiliation":[{"name":"Departments of Exploratory Science, Molecular Genetics and Protein Engineering, Biogen Inc., 12 Cambridge Center, Cambridge, Massachusetts 02142, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda C.","family":"Burkly","sequence":"additional","affiliation":[{"name":"Departments of Exploratory Science, Molecular Genetics and Protein Engineering, Biogen Inc., 12 Cambridge Center, Cambridge, Massachusetts 02142, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"237","reference":[{"key":"2021042522501158300_BIANCONE-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Biancone, L., Martino, A. D., Orlandi, V., Conaldi, P. G., Toniolo, A. and Camussi, G. (1997). Development of inflammatory angiogenesis by local stimulation of Fas in vivo. J. Exp. Med.186, 147-152.","DOI":"10.1084\/jem.186.1.147"},{"key":"2021042522501158300_BUSSOLINO-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Bussolino, F., Mantovani, A. and Persico, G. (1997). Molecular mechanisms of blood vessel formation. Trends Biochem. Sci.22, 251-256.","DOI":"10.1016\/S0968-0004(97)01074-8"},{"key":"2021042522501158300_CARMELIET-2000","doi-asserted-by":"crossref","unstructured":"Carmeliet, P. (2000). Mechanisms of angiogenesis and arteriogenesis. Nat. Med.6, 389-395.","DOI":"10.1038\/74651"},{"key":"2021042522501158300_CHICHEPORTICHE-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Chicheportiche, Y., Bourdon, P. R., Xu, H., Hsu, Y. M., Scott, H., Hession, C., Garcia, I. and Browning, J. L. (1997). TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem.272, 32401-32410.","DOI":"10.1074\/jbc.272.51.32401"},{"key":"2021042522501158300_ELICEIRI-AND-CHERESH-1999","doi-asserted-by":"crossref","unstructured":"Eliceiri, B. P. and Cheresh, D. A. (1999). The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J. Clin. Invest.103, 1227-1230.","DOI":"10.1172\/JCI6869"},{"key":"2021042522501158300_FAJARDO-ETAL-1992","unstructured":"Fajardo, L. F., Kwan, H. H., Kowalski, J., Prionas, S. D. and Allison, A. C. (1992). Dual role of tumor necrosis factor-alpha in angiogenesis. Am. J. Pathol.140, 539-544."},{"key":"2021042522501158300_FOLKMAN-1995","doi-asserted-by":"crossref","unstructured":"Folkman, J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27-31.","DOI":"10.1038\/nm0195-27"},{"key":"2021042522501158300_FONG-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Fong, G. H., Rossant, J., Gertsenstein, M. and Breitman, M. L. (1995). Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature376, 66-70.","DOI":"10.1038\/376066a0"},{"key":"2021042522501158300_FRATER-SCHRODER-ETAL-1987","doi-asserted-by":"crossref","unstructured":"Frater-Schroder, M., Risau, W., Hallmann, R., Gautschi, P. and Bohlen, P. (1987). Tumor necrosis factor type \u03b1, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc. Natl. Acad. Sci. USA84, 5277-5281.","DOI":"10.1073\/pnas.84.15.5277"},{"key":"2021042522501158300_HAN-AND-LIU-1999","unstructured":"Han, Z. C. and Liu, Y. (1999). Angiogenesis: state of the art. Int. J. Hematol.70, 68-82."},{"key":"2021042522501158300_KAPSTEIN-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Kapstein, A., Jansen, M., Dilaver, G., Kitson, J., Dash, L., Wang, E., Owen, M. J., Bodmer, J., Tschopp, J. and Farrow, S. N. (2000). Studies on the interaction between TWEAK and the death receptor WSL-1\/TRAMP (DR3). FEBS Lett.485, 135-141.","DOI":"10.1016\/S0014-5793(00)02219-5"},{"key":"2021042522501158300_KOOLWIJK-ETAL-1996","unstructured":"Koolwijk, P., M., van Erck, M. G., de Vree, W. J. A., Verneer, M. A., Weich, H. A., Hanemaaijer, R. and van Hinsbergh, V. W. M. (1996). Cooperative effect of TNF\u03b1, bFGF and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity. J. Biol. Chem.132, 1177-1188."},{"key":"2021042522501158300_KORPELAINEN-AND-ALITALO-1998","doi-asserted-by":"crossref","unstructured":"Korpelainen, E. I. and Alitalo, K. (1998). Signalling angiogenesis and lymphangiogenesis. Curr. Opin. Cell Biol.10, 159-164.","DOI":"10.1016\/S0955-0674(98)80137-3"},{"key":"2021042522501158300_LEIBOVICH-ETAL-1987","doi-asserted-by":"crossref","unstructured":"Leibovich, S. J., Polverini, P. J., Shepard, H. M., Wiseman, D. M., Shively, V. and Nuseir, N. (1987). Macrophage-induced angiogenesis is mediated by tumour necrosis factor- alpha. Nature329, 630-632.","DOI":"10.1038\/329630a0"},{"key":"2021042522501158300_LOCKSLEY-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Locksley, R. M., Killeen, N. and Lenardo, M. J. (2001). The TNF and TNF Receptor Superfamilies. Integrating mammalian biology. Cell104, 487-501.","DOI":"10.1016\/S0092-8674(01)00237-9"},{"key":"2021042522501158300_LYNCH-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Lynch, C. N., Wang, Y. C., Lund, J. K., Chen, Y., Leal, J. and Wiley, S. R. (1999). TWEAK induces angiogenesis and proliferation of endothelial cells. J. Biol. Chem.274, 8455-8459.","DOI":"10.1074\/jbc.274.13.8455"},{"key":"2021042522501158300_MACH-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Mach, F., Schonbeck, U., Fabunmi, R. P., Murphy, C., Atkinson, E., Bonnefoy, J. Y., Graber, P. and Libby, P. (1999). T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation. Am. J. Pathol.154, 229-238.","DOI":"10.1016\/S0002-9440(10)65269-8"},{"key":"2021042522501158300_MARSTERS-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Marsters, S. S., Sheridan, J. P., Pitti, R. M., Brush, J., Goddard, A. and Ashkenazi, A. (1998). Identification of a ligand for the death-domain-dontaining receptor Apo3. Curr. Biol.8, 525-528.","DOI":"10.1016\/S0960-9822(98)70204-0"},{"key":"2021042522501158300_MORALES-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Morales, D. E., McGowan, K., Grant, D., Maheshwari, S., Bhartiya, D., Cid, M. C., Kleinman, H. K. and Schnaper, W. (1995). Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation91, 755-763.","DOI":"10.1161\/01.CIR.91.3.755"},{"key":"2021042522501158300_NAKAYAMA-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Nakayama, M., Kayagaki, N., Yamaguchi, N., Okumura, K. and Yagita, H. (2000). Involvement of TWEAK in interferon \u03b3-stimulated monocyte cytotoxicity. J. Exp. Med.192, 1373-1379.","DOI":"10.1084\/jem.192.9.1373"},{"key":"2021042522501158300_NOR-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Nor, J. E., Christensen, J., Mooney, D. J. and Polverini, P. J. (1999). Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl- 2 expression. Am. J. Pathol.154, 375-384.","DOI":"10.1016\/S0002-9440(10)65284-4"},{"key":"2021042522501158300_RUEGG-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Ruegg, C., Yilmaz, A., Bieler, G., Bamat, J., Chaubert, P. and Lejeune, F. J. (1998). Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma. Nat. Med.4, 408-414.","DOI":"10.1038\/nm0498-408"},{"key":"2021042522501158300_SAAS-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Saas, P., Boucraut, J., Walker, P. R., Quiquerez, A., Billot, M., Desplat-Jego, S., Chicheportiche, Y. and Dietrich, P. (2000). TWEAK stimulation of astrocytes and the proinflammatory consequences. GLIA32, 102-107.","DOI":"10.1002\/1098-1136(200010)32:1<102::AID-GLIA100>3.0.CO;2-U"},{"key":"2021042522501158300_SCHNEIDER-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Schneider, P., Schwenzer, R., Haas, E., Muhlenbeck, F., Schubert, G., Scheurich, P., Tschopp, J. and Wajant, H. (1999). TWEAK can induce cell death via endogenous TNF and TNF receptor 1. Eur. J. Immunol.29, 1785-1792.","DOI":"10.1002\/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U"},{"key":"2021042522501158300_SENGER-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Senger, D. R., Claffey, K. P., Benes, J. E., Perruzzi, C. A., Sergiou, A. P. and Detmar, M. (1997). Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc. Natl. Acad. Sci. USA94, 13612-13617.","DOI":"10.1073\/pnas.94.25.13612"},{"key":"2021042522501158300_SMITH-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Smith, C. A., Farrah, T. and Goodwin, R. G. (1994). The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell76, 959-962.","DOI":"10.1016\/0092-8674(94)90372-7"},{"key":"2021042522501158300_TERUI-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Terui, Y., Ikeda, M., Tomizuka, H., Kasahara, T., Ohtsuki, T., Uwai, M., Mori, M., Itoh, T., Tanaka, M., Yamada, M. et al. (\n          1998). Activated endothelial cells induce apoptosis in leukemic cells by endothelial interleukin-8. Blood92, 2672-2680.","DOI":"10.1182\/blood.V92.8.2672.420k40_2672_2680"},{"key":"2021042522501158300_THOMAS-1996","doi-asserted-by":"crossref","unstructured":"Thomas, K. A. (1996). Vascular endothelial growth factor, a potent and selective angiogenic agent. J. Biol. Chem.271, 603-606.","DOI":"10.1074\/jbc.271.2.603"},{"key":"2021042522501158300_YOSHIDA-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Yoshida, S., Ono, M., Shono, T., Izumi, H., Ishibashi, T., Suzuki, H. and Kuwano, M. (1997). Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol. Cell Biol.17, 4015-4023.","DOI":"10.1128\/MCB.17.7.4015"},{"key":"2021042522501158300_YUE-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Yue, T., Ni, J., Romanic, A. M., Gu, J. L., Keller, P., Wang, C., Kumar, S., Yu, G. L., Hart, T. K., Wang, X. et al. (\n          1999). TL1, A novel tumor necrosis factor-like cytokine induces apoptosis in endothelial cells. J. Biol. Chem.274, 1479-1486.","DOI":"10.1074\/jbc.274.3.1479"},{"key":"2021042522501158300_ZHAI-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Zhai, Y., Ni, J., Jiang, G. W., Lu, J., Xing, L., Lincoln, C., Carter, K. C., Janat, F., Kozak, D., Xu, S. et al. (\n          1999). VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo. Faseb J.13, 181-189.","DOI":"10.1096\/fasebj.13.1.181"}],"container-title":["Journal of Cell Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.biologists.com\/jcs\/article-pdf\/115\/2\/267\/1476101\/267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/journals.biologists.com\/jcs\/article-pdf\/115\/2\/267\/1476101\/267.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T23:32:21Z","timestamp":1619393541000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/jcs\/article\/115\/2\/267\/34767\/Dual-role-for-TWEAK-in-angiogenic-regulation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1,15]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,1,15]]}},"URL":"https:\/\/doi.org\/10.1242\/jcs.115.2.267","relation":{},"ISSN":["1477-9137","0021-9533"],"issn-type":[{"value":"1477-9137","type":"electronic"},{"value":"0021-9533","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1,15]]}}}